drugset / Trial / NCT04850898
Study of SAB-176 in Healthy Adult Participants
RandomizedParallel-groupTriple-blindTreatment
Summary
Healthy adult participants will be challenged with the H1N1 Influenza virus and then treated with either SAB-176 or placebo.
Timeline
- Start
- 2021-06-23
- Primary completion
- 2021-10-08
- Completion
- 2021-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SAB-176 | Protein / enzyme biologic | 25 mg/kg | Intravenous |